Interpace Biosciences 10K 2018 Annual report | IDXG Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: AACE, Abbott, Accel, Acupath, adjunct, affiliate, affiliated, affirmative, agenda, aggressive, AJ, algorithm, Aon, ArrayJet, auto, automated, Bachelor, BarreGEN®, BarreGEN®for, Becton, Belt, Bennet, billable, bioanalytical, bioartificial, BioPharma, BioreclamationIVT, Bioresearch, bioscience, biotech, BJC, blinded, BMJ, Boston, Braun, bribe, broaden, built, calledin, candidate, carcinoma, career, carryforward, Carterra, category, cautioned, cell, CEO, Chair, chairperson, charter, Children, choice, circulating, Clin, clinician, closer, COBRA, column, comment, commerce, commercializenewmolecular, Commonwealth, composed, constrain, Covance, covertly, creditor, CRO, CTC, Culture, Cytometry, DAIA, Dame, Das, Dayton, delinquent, depressive, developmental, Diagn, Dickinson, disability, disregarded, doi, dollar, driven, Dx, dysplasia, EKRA, Eluri, employ, employed, encumber, encumbered, Endosc, endoscopic, Endoscopyincluded, enterprise, Eventsof, excessive, Exiqon, expert, expressly, factor, Farrell, FFPE, fifteen, Firma, FISH, footnote, formula, ForteBio, founder, Francisco, Fulton, Gastro, Gastroenterol, Gastrointest, Genentech, genotyping, Georgetown, Georgia, gie, gold, Gonda, graduated, Green, Gregory, grew, Halo, Harlan, head, heading, Hepatology, Hewitt, highlighting, histological, home, hour, hourly, HS, immunology, implicated, improperly, inAthena, indefinitely, inEndoscopy, Influmedix, inGastrointestinal, injectable, instrument, Int, interstate, invoiced, invoicing, Irrespective, IVCT, IVD, Jan, Jay, JCEM, JE, JJ, joined, joining, JOP, Joseph, Journal, JW, Keegan, Khara, Khosaravi, kickback, kinase, kind, Kowalski, Kumar, Kung, Kushnir, Labcyte, Labourier, LeBow, led, Lehigh, Leica, linking, liver, longitudinal, Loren, lump, Lybrand, MA, manuscript, Marine, MDCC, metaplasia, MI, microbiology, Microscopy, Missouri, mitigate, Monahan, Mount, multicenter, multivariate, muscle, myeloma, Nano, Nanomedical, Nashville, neurotransmission, nominal, Nominating, nomination, noncompliance, Northeast, Notre, NRV, Obama, Onconova, Opera, optimize, orphan, overtly, Pall, PancraGEN®reclassification, PancraGEN®testing, PancraGEN®to, papillary, paragraph, passage, Pathol, patronage, PharmaStart, PHI, Philadelphia, PHT, Piedmont, Plainview, Poster, precertification, preclinical, predecessor, Premarket, preoperative, prepay, Presbyterian, Professor, proprietor, Qiagen, Quadrant, Radford, ran, reassessment, rebate, regular, regulatesin, RespriDx®in, restoration, revoking, Richard, Richardworked, round, San, satisfactory, School, scientificchange, Scottish, seasonal, sector, semiconductor, SHOP, Sicor, Sigma, Signal, Silicon, Sinai, Sistrunk, sitting, slide, speaker, Sr, St, stained, standing, Stanford, strain, Strata, strongly, successor, Summit, Sunshine, SVB, Synageva, TA, Teva, thatthe, theft, Thelimitationcould, thosein, thygenext, ThyGeNEXT®and, ThyGeNEXT®test, ThyGenNEXT, ThyGenX®combination, ThyGenX®of, ThyraMIR®in, TM, TN, toreplaceand, Transnetyx, travel, Trindade, true, Trump, tyrosine, UCLA, unconditional, undergone, underwent, unexercised, unreasonable, unreserved, upgrade, UPMC, upward, vaccine, Valley, Vanderbilt, Viatar, vitrodiagnostic, VM, VUMC, Wainwright, Wall, Wasatch, Weill, Westminster, Wharton, women, worrisome, wrongful, Wylie, Xenometrix, XIFIN, Zebec

Removed: arrive, article, assumption, automatically, bundle, buyer, capita, categorize, cliff, closeout, commit, Condensed, convert, County, covenant, cystic, depict, Docket, EUS, exercising, expiration, exposing, faith, forgoing, fundamental, Gerald, goodwill, Graham, hormone, inaccuracy, Intercreditor, IPAB, Krishnamurti, lifetime, Lurker, Melillo, Miao, Nancy, Nat, nationwide, noncurrent, nonvested, packaging, payor, pro, Procedural, promissory, propose, referenced, responsive, Sendai, Terminology, therapy, threshold, Thymira, Traditionally, warranty, withhold, wrongfully

Interpace Biosciences (IDXG) 10-K2018 FY Annual report

Content analysis